103 filings
ARS
2023 FY
ALXO
Alx Oncology Holdings Inc
22 Apr 24
Annual report to shareholders
6:09pm
DEF 14A
ALXO
Alx Oncology Holdings Inc
Definitive proxy
22 Apr 24
4:01pm
S-8
ALXO
Alx Oncology Holdings Inc
7 Mar 24
Registration of securities for employees
7:56pm
10-K
2023 FY
ALXO
Alx Oncology Holdings Inc
Annual report
7 Mar 24
4:11pm
8-K
ALXO
Alx Oncology Holdings Inc
7 Mar 24
ALX Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
4:05pm
8-K
7n2i0xyr5n427f
26 Dec 23
Entry into a Material Definitive Agreement
4:01pm
8-K
qog53x5zs8fl69dn5g
13 Nov 23
ALX Oncology Reports Third Quarter 2023 Financial Results and Provides Corporate Update
4:03pm
8-K
xcyxf 593m89p
6 Oct 23
ALX Oncology Announces Pricing of Public Offering
6:06am
424B5
uft8vn5iloxz a5ifc57
6 Oct 23
Prospectus supplement for primary offering
6:05am
8-K
bqkb qul2wtq
4 Oct 23
Results of Operations and Financial Condition
5:21pm
424B5
j8p4xjopo8994
4 Oct 23
Prospectus supplement for primary offering
5:21pm
8-K
19t4zo9wdyvmv8p
4 Oct 23
Other Events
8:00am
EFFECT
ci7kkggq1am3a0m
11 Sep 23
Notice of effectiveness
12:15am
424B3
eajzflbbmsz2n
8 Sep 23
Prospectus supplement
4:25pm
CORRESP
460g0z p5n
7 Sep 23
Correspondence with SEC
12:00am
8-K
en8l21twf82bcnmot2ae
6 Sep 23
Departure of Directors or Certain Officers
4:05pm
UPLOAD
p0nb6hzj 4b
6 Sep 23
Letter from SEC
12:00am
424B5
jjrkv
25 Aug 23
Prospectus supplement for primary offering
4:44pm